Pediatric Patients with Type 1 Diabetes In a randomized, controlled clinical study (Study D), pediatric patients (age range 6 to 15 years) with type 1 diabetes (n = 349) were treated for 28 weeks with a basal-bolus insulin regimen where regular human insulin was used before each meal
Conversely, constipation may lead to hard stools, straining, and hemorrhoidal engorgement
Consume protein-rich meals and snacks throughout the day to support muscle protein synthesis
Many participants in the trial reported gastrointestinal issues, such as nausea and vomiting, when taking the medication
Selected patients may be evaluated for phentermine, Qsymia, Contrave, diethylpropion, phendimetrazine, orlistat, topiramate or another appropriate option